Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill expanding Prescription Drug Affordability Board authority to consider upper payment limits, adds Medicaid consultation requirement
Summary
The Health and Government Operations Committee voted to advance House Bill 424, giving the Prescription Drug Affordability Board discretion to pursue upper payment limits for prescription drugs in Maryland and requiring the board to consult with Medicaid before setting limits that may affect the program.
The Health and Government Operations Committee on Friday voted to advance House Bill 424, which would expand the Prescription Drug Affordability Board’s (PDAB) authority to determine whether to set upper payment limits (UPLs) for purchases and payer reimbursements of prescription drugs in Maryland and to establish a specified process for setting those limits.
The bill, described by committee staff, removes certain existing reporting requirements about UPLs, authorizes (rather than mandates) an expansion of UPL authority, and adds new authority for the board…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
